{"disease":{"id":"refractory-and-relapsed-b-cell-acute-leukemia","name":"refractory and relapsed b cell acute leukemia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04508842","title":"CD19/CD22-Dual-STAR-T for Patients With B Cell Acute Leukemia(B-ALL)","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"Hebei Yanda Ludaopei Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}